CN1051909A - The process modification of captopril - Google Patents

The process modification of captopril Download PDF

Info

Publication number
CN1051909A
CN1051909A CN 89108856 CN89108856A CN1051909A CN 1051909 A CN1051909 A CN 1051909A CN 89108856 CN89108856 CN 89108856 CN 89108856 A CN89108856 A CN 89108856A CN 1051909 A CN1051909 A CN 1051909A
Authority
CN
China
Prior art keywords
acetylthio
proline
pro
methyl
methyl propionyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 89108856
Other languages
Chinese (zh)
Other versions
CN1021044C (en
Inventor
谢美华
宁奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Institute of Pharmaceutical Industry
Original Assignee
Shanghai Institute of Pharmaceutical Industry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Institute of Pharmaceutical Industry filed Critical Shanghai Institute of Pharmaceutical Industry
Priority to CN 89108856 priority Critical patent/CN1021044C/en
Publication of CN1051909A publication Critical patent/CN1051909A/en
Application granted granted Critical
Publication of CN1021044C publication Critical patent/CN1021044C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Captopril is an angiotensin converting enzyme inhibitor, is the novel hypertension and the medicine of congestive heart failure.It is condensing agent with alkaline matters such as sodium hydroxide that the present invention adopts 3-acetylthio-2-methyl-prop acyl chlorides and L-proline(Pro), in organic solvents such as water or ethanol, acetone, tetrahydrofuran (THF), react, directly make D-3-acetylthio-2-methyl propionyl-L-proline(Pro), raw materials for production cost and man-hour reduce by 40% than existing operational path.

Description

The process modification of captopril
Captopril is an angiotensin converting enzyme inhibitor, be the novel hypertension and the medicine of congestive heart failure, U.S. FDA was in approval listing in 1981, now obtain obvious curative effects through extensive clinical verification, become one of world's situation of selling well medicine since in 1987, ranked the 4th.The existing manufacturing technique route is as follows:
Figure 891088563_IMG1
This reaction scheme is that 3-acetylthio-2-methyl-prop acyl chlorides (I) and the condensation of L proline(Pro) are made-3-acetylthio-2-methyl propionyl-L-proline(Pro) (II), the latter and bicyclohexylamine salify get thick amine salt, again through Virahol refining D-amine salt (III), free with sal enixum subsequently, obtain D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV), after hydrolysis, make captopril (V).Aforesaid method once by Ondetti MA in 1977 at U.S. Patent number 4,046,889 and Jose AJ equal on Span ES 497,020, to do respectively in 1981 report.But the aforesaid method reactions steps is long, and needs to carry out the separation of optical isomer with two cyclic group amine, the production cost height.For overcoming these shortcomings, we have carried out the research of process modification, and operational path of the present invention is as follows:
Technology of the present invention be with 3-acetylthio-2-methyl-prop acyl chlorides (I) and L-proline(Pro) in water or ethanol, acetone, tetrahydrofuran (THF) equal solvent, adopt potassium hydroxide, sodium hydroxide or pyridine, triethylamine etc. are inorganic or organic bases is made condensing agent, consumption with 1: 1~3 ratios, in-5~20 ℃, reacted under the condition of PH5~10 0.5~3 hour, and directly made D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV).The present invention need not adopt any reagent to carry out the separation of optical isomer, and has got rid of dicyclohexyl amine, Virahol, has greatly simplified production technique, makes raw materials cost reduce 40% man-hour with producing.
Embodiment one
Preparation D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV)
With 23.7g(0.21M) the L-proline(Pro) is dissolved in the 100ml water, is cooled to-5~0 ℃, under agitation condition, drip 2N NaOH, making solution PH is 8~9, under uniform temp, drips NaOH and 3-acetylthio-2-methyl-prop acyl chlorides (I) 37.9g(0.21M simultaneously then), in the dropping process, control PH8~9, after dropwising, under the PH7 condition, reactant was stirred 0.5 hour, reaction solution washs 3 times with ethyl acetate, divide and to remove ethyl acetate layer, the aqueous solution is acidified to PH2 in stirring at room 5 hours, 10 ℃ of standing over night with 6N HCl, filter, collecting precipitation washes with water, gets 20g product, yield 36% after the drying, 70~80 ℃ of fusing points, [α] 20 D-155~170 ° (C, 1,95%EtOH).
Ultimate analysis: C 11H 17O 4NSH 2O
Calculated value %:C 47.64, H 6.95, and N 5.41, and S 11.2
Experimental value %:C 48.10, H 7.31, and N 5.45, and S 11.61
Embodiment two
Preparation D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV)
With 23.7g(0.21M) the L-proline(Pro) is dissolved in the 100ml50% ethanol, be cooled to-5~0 ℃, under agitation condition, in solution, drip triethylamine, making its PH is 8~9, under uniform temp, drip triethylamine and 3-acetylthio-2-methyl-prop acyl chlorides (I) 37.9g(0.21M simultaneously then), in the dropping process, control PH8~9, after dropwising, under the PH7 condition, reactant was stirred 0.5 hour, remove ethanol under reduced pressure after, reaction solution washs 3 times with ethyl acetate, divide and to remove ethyl acetate layer, the aqueous solution was acidified to PH2 with 6N HCl, in stirring at room 6 hours, 10 ℃ of standing over night, filter, collecting precipitation washes with water, get the 20g product after the drying, yield 36%, fusing point: 80~82 ℃, [α] 20 D-155~170 ° (C, 1,95%EtOH).
Ultimate analysis: C 11H 17O 4NS
Calculated value %:C 50.94, H 6.61, and N 5.40, and S 12.36
Experimental value %:C 50.47 H 6.87, N 5.54, and S 11.98

Claims (3)

1, a kind of method for preparing D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV), it is characterized in that with 3-acetylthio-2-methyl-prop acyl chlorides (I) and-the L-proline(Pro) is in water or organic solvent, adopt mineral alkali or organic bases to make condensing agent, consumption with 1: 1~3 ratios, in-5~20 ℃, reacted under the condition of PH5~10 0.5~3 hour, and made D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV).
2, by the described method for preparing D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV) of claim 1, organic solvent wherein is ethanol, acetone or tetrahydrofuran (THF) etc.
3, by the described method for preparing D-3-acetylthio-2-methyl propionyl-L-proline(Pro) (IV) of claim 1, mineral alkali wherein is potassium hydroxide or sodium hydroxide etc., and the machine alkali that wherein has is pyridine or triethylamine etc.
CN 89108856 1989-11-24 1989-11-24 Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline Expired - Lifetime CN1021044C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 89108856 CN1021044C (en) 1989-11-24 1989-11-24 Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 89108856 CN1021044C (en) 1989-11-24 1989-11-24 Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline

Publications (2)

Publication Number Publication Date
CN1051909A true CN1051909A (en) 1991-06-05
CN1021044C CN1021044C (en) 1993-06-02

Family

ID=4857773

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 89108856 Expired - Lifetime CN1021044C (en) 1989-11-24 1989-11-24 Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline

Country Status (1)

Country Link
CN (1) CN1021044C (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102452970A (en) * 2010-10-16 2012-05-16 华中药业股份有限公司 Preparation method of D-3-bromine-2-methyl propionyl-L-proline
CN104513292A (en) * 2013-09-29 2015-04-15 山东新时代药业有限公司 Preparation method of ramipril

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102452970A (en) * 2010-10-16 2012-05-16 华中药业股份有限公司 Preparation method of D-3-bromine-2-methyl propionyl-L-proline
CN104513292A (en) * 2013-09-29 2015-04-15 山东新时代药业有限公司 Preparation method of ramipril

Also Published As

Publication number Publication date
CN1021044C (en) 1993-06-02

Similar Documents

Publication Publication Date Title
AU702141B2 (en) Process for preparing enantiomerically pure tropic acid esters
NO144169B (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC APPLICABLE 6- (D (-) - ALFA-AMINOPHENYLACETAMIDO) PENICILLANIC ACID PHALIDESTES
CN102617481A (en) Preparation method of rosuvastatin calcium
CN107857743A (en) A kind of method for preparing hydrochloric acid roxatidine acetate and intermediate
CN1021044C (en) Preparation method for acidophobic-methyl propyl proline intermediate d-3-acetylsulfuric-2-methyl-propiony-l-proline
CN1137998C (en) Zymolysis process of producing heparin sodium
CN113667007B (en) Liquid phase preparation method of cable Ma Lutai side chain
EP0048345B1 (en) Process for the preparation of an alpha-l-aspartyl-l-phenylalanine-alkyl ester
CN101074446A (en) Decomposition of tert-leucine with optical activity
CN114014863B (en) Preparation method of bone marrow protective agent traasiril
CN1953986B (en) Purification of N-(phosphonomethyl)glycine
US4065353A (en) Method for the preparation of D-carbamyl aminoacids and the corresponding D-aminoacids
CN1036340C (en) Alpha-hydroxy-r-amino-butyric acid synthetic process
CN100404548C (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
CN111995652B (en) Method for separating chenodeoxycholic acid from duck bile
CN116554088A (en) Preparation method of lobelia hydrochloride
CN1837105A (en) Process for treating wastewater from preparation of N-(phosphonomethyl) iminodiacetic acid as synthetic intermediate of glyphosate
JP3884493B2 (en) Process for producing fluorinated β-xylobiosyl and xylooligosaccharide
CN1034328C (en) Method for preparation of ferulic acid, sodium ferulate, sterol from ferulic acid ester
CN1102409A (en) Process for the preparation of indoles
CN101851285A (en) Method for preparing sulglycotide
CH513125A (en) Tetrapeptides and derivs
CN101289417A (en) Process for preparing D-3-thioacetyl-2-methylpropionyl-L-proline
CA1245667A (en) Process and intermediates for sorbinil
JPS59500647A (en) Process for producing 6-deoxy-D-fructose and 6-deoxy-L-sorbose

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C17 Cessation of patent right
CX01 Expiry of patent term

Granted publication date: 19930602